Barinthus Biotherapeutics Plc. - ADR
BRNS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.23M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $30.23 Million |
|---|---|
| Enterprise Value | $-18,432,734.00 |
| Earnings per Share | $-1.64 |
| Beta | -0.36 |
| Outstanding Shares | 40,848,893 |
Return
| Return on Equity | -73.18% |
|---|---|
| Return on Assets | -51.00% |
| Return on Invested Capital | -23.44% |
Valuation & Multiples
| P/E Ratio | -0.72 |
|---|---|
| PEG | 1.44 |
| Price to Sales | - |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.12 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.58 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.28
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.26
Consensus analyst estimateRevenue Estimate
$216,900
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Barinthus Biotherapeutics Plc.
109 employees
vaccitech is a spin-out company from the university of oxford’s jenner institute, one of the oldest and most renowned vaccine research centres in the world. the company has been formed around two viral vector vaccines, one to prevent inf...